Title of article
Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL
Author/Authors
Mali، نويسنده , , Raghuveer Singh and Ramdas، نويسنده , , Baskar and Ma، نويسنده , , Peilin and Shi، نويسنده , , Jianjian and Munugalavadla، نويسنده , , Veerendra and Sims، نويسنده , , Emily and Wei، نويسنده , , Lei and Vemula، نويسنده , , Sasidhar and Nabinger، نويسنده , , Sarah C. and Goodwin، نويسنده , , Charles B. and Chan، نويسنده , , Rebecca J. and Traina، نويسنده , , Fabiola and Visconte، نويسنده , , Valeria and Tiu، نويسنده , , Ramon V. and Lewis، نويسنده , , Timothy A. and Stern، نويسنده , , Andrew M. and Wen، نويسنده , , Qiang and Crispino، نويسنده , , John D. and Boswell، نويسنده , , H. Scott and Kapur، نويسنده , , Reuben، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2011
Pages
13
From page
357
To page
369
Abstract
Summary
w constitutive activation of Rho kinase (ROCK) in cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL, which is dependent on PI3K and Rho GTPase. Genetic or pharmacologic inhibition of ROCK in oncogene-bearing cells impaired their growth as well as the growth of acute myeloid leukemia patient-derived blasts and prolonged the life span of mice bearing myeloproliferative disease. Downstream from ROCK, rapid dephosphorylation or loss of expression of myosin light chain resulted in enhanced apoptosis, reduced growth, and loss of actin polymerization in oncogene-bearing cells leading to significantly prolonged life span of leukemic mice. In summary we describe a pathway involving PI3K/Rho/ROCK/MLC that may contribute to myeloproliferative disease and/or acute myeloid leukemia in humans.
Journal title
Cancer Cell
Serial Year
2011
Journal title
Cancer Cell
Record number
1337626
Link To Document